23.14 USD
+0.1 (+0.43%)
Overall PRVA gets a fundamental rating of 4 out of 10. We evaluated PRVA against 100 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, PRVA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year PRVA was profitable.
In the past year PRVA had a positive cash flow from operations.
In multiple years PRVA reported negative net income over the last 5 years.
PRVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 1.34%, PRVA perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 57.00% of its industry peers.
PRVA has a Return On Invested Capital (2.45%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PRVA (0.89%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of PRVA has declined.
Looking at the Operating Margin, with a value of 1.38%, PRVA is in line with its industry, outperforming 46.00% of the companies in the same industry.
In the last couple of years the Operating Margin of PRVA has declined.
With a Gross Margin value of 10.17%, PRVA is not doing good in the industry: 74.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRVA is destroying value.
The number of shares outstanding for PRVA has been increased compared to 1 year ago.
The number of shares outstanding for PRVA has been increased compared to 5 years ago.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.40 indicates that PRVA is not in any danger for bankruptcy at the moment.
PRVA has a Altman-Z score of 4.40. This is in the better half of the industry: PRVA outperforms 80.00% of its industry peers.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.4 |
ROIC/WACC0.27
WACC8.95%
2.3 Liquidity
PRVA has a Current Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
PRVA has a better Current ratio (1.67) than 64.00% of its industry peers.
PRVA has a Quick Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
PRVA's Quick ratio of 1.67 is fine compared to the rest of the industry. PRVA outperforms 69.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.00% over the past year.
The Earnings Per Share has been growing slightly by 7.43% on average over the past years.
PRVA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.01%.
The Revenue has been growing by 17.17% on average over the past years. This is quite good.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
PRVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.59% yearly.
PRVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.73% yearly.
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PRVA is valuated quite expensively with a Price/Earnings ratio of 178.00.
PRVA's Price/Earnings is on the same level as the industry average.
PRVA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.19.
PRVA is valuated quite expensively with a Price/Forward Earnings ratio of 72.22.
The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (23.92), we can say PRVA is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 178 | ||
| Fwd PE | 72.22 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRVA indicates a slightly more expensive valuation: PRVA is more expensive than 62.00% of the companies listed in the same industry.
PRVA's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.71 | ||
| EV/EBITDA | 64.17 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
PRVA's earnings are expected to grow with 69.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.09
PEG (5Y)23.94
EPS Next 2Y70.67%
EPS Next 3Y69.59%
5. Dividend
5.1 Amount
PRVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PRVA (1/12/2026, 12:29:17 PM)
23.14
+0.1 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.68%
Inst Owner Change0.02%
Ins Owners1.85%
Ins Owner Change0.2%
Market Cap2.85B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.18 (39.07%)
Short Float %2.62%
Short Ratio4.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)0.48%
PT rev (3m)3.18%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-43.41%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-19.32%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)8.01%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)4.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 178 | ||
| Fwd PE | 72.22 | ||
| P/S | 1.39 | ||
| P/FCF | 25.71 | ||
| P/OCF | 25.71 | ||
| P/B | 4.01 | ||
| P/tB | 7.71 | ||
| EV/EBITDA | 64.17 |
EPS(TTM)0.13
EY0.56%
EPS(NY)0.32
Fwd EY1.38%
FCF(TTM)0.9
FCFY3.89%
OCF(TTM)0.9
OCFY3.89%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.09
PEG (5Y)23.94
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.4 |
F-Score7
WACC8.95%
ROIC/WACC0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
Can you provide the valuation status for PRIVIA HEALTH GROUP INC?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for PRVA stock?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 178 and the Price/Book (PB) ratio is 4.01.
Can you provide the financial health for PRVA stock?
The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.